
There are more than 290,000 people estimated to be living in the United States with a spinal cord injury. Previously, it has been shown that it is possible to restore some function to young and healthy patients within a few years of injury. Now, researchers show spinal cord stimulation can immediately restore some voluntary movement and autonomic functions such as cardiovascular, bowel, and bladder years after a paralyzing injury without any significant rehabilitation.
“This was an opportunity to use epidural stimulation, combine my background in mathematics, collaborate with people from multiple disciplines including biomedical engineering and set up a truly innovative trial,” said Dr. David Darrow, a neurosurgery resident at the University of Minnesota Medical School and a lead investigator for the E-STAND Clinical trial. He is also a senior neurosurgery resident at Hennepin Healthcare and University of Minnesota Medical Center. “We wanted to push the envelope for patients. Once we determined it worked, we moved on to knocking down other barriers to translation to patient care.”
In a study recently published in the Journal of Neurotrauma, Darrow and his colleagues implanted the first series of female patients who both suffered devastating traumatic spinal cord injury. Both patients had no lower body function whatsoever and MRIs showing very little residual spinal cord at the level of injury. The two women were five and ten years from injury and in their 5th and 6th decade of life, which is much closer to the average patient with spinal cord injury compared to the work of other investigators.
“Enabling someone to move her legs more than 10 years after being paralyzed from spinal cord injury has been one of the greatest moments of my career,” said Uzma Samadani, MD, PhD, Associate Professor in the Department of Neurosurgery University of Minnesota Medical School and Neurosurgeon with Hennepin Healthcare. “I am grateful to my colleagues for their mutual hard work during the 2 years it took to get from idea to the first operation.”
In this study, researchers expanded the inclusion guidelines of who could receive epidural stimulation.
“We believe that we are studying a population that is much closer to the general population of patients with spinal cord injury,” said Darrow. “We have opened the doors to so many more patients with traumatic spinal cord injury.”
“While we are excited for all this could mean for patients, there is still a lot of research to be done, both with this therapy and through other avenues, many of which we are studying at the University of Minnesota,” said Ann M. Parr, MD, PhD, Assistant Professor in the Department of Neurosurgery at the University of Minnesota Medical School. Dr. Parr has an active translational spinal cord injury research laboratory at the Stem Cell Institute.
This work was made possible by a grant through the Minnesota Office of Higher Education SCI/TBI Grant Program and collaboration of an interdisciplinary group spread across four institutions. The stimulation devices were a gift from Abbott (formerly St. Jude’s).
The Latest on: Spinal cord stimulation
[google_news title=”” keyword=”spinal cord stimulation” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Spinal cord stimulation
- Medtronic: An Engineer and the Earthworms That Revolutionized Spinal Cord Stimulationon July 31, 2024 at 9:31 am
Insights from the study of nightcrawlers contributed to a key advancement in the treatment of chronic pain NORTHAMPTON, MA / ACCESSWIRE / July 31, 2024 / In 2010, engineer David Dinsmoor was looking ...
- Using ECAP Dose-Controlled CL Therapy to Identify Post SCS Responders Postoperativelyon July 31, 2024 at 8:05 am
The following is a summary of “Identifying SCS Trial Responders Immediately After Postoperative Programming with ECAP Dose-Controlled Closed-Loop Therapy,” published in the July 2024 issue of Pain by ...
- Does SCS Boost Emotional, Psychosocial Well-Being in Patients With Chronic Pain?on July 31, 2024 at 5:57 am
At 1 year after SCS implantation, functional, emotional, and psychosocial domains were significantly improved among patients with chronic pain.
- WISE Completes New Financing Round To Accelerate Development Of Heron® Leadon July 30, 2024 at 12:39 am
MILAN, ITALY, July 30, 2024 /EINPresswire / -- .The Heron® lead is the first unidirectional multicolumn lead for spinal cord stimulation that can be implanted percutaneously for chronic pain treatment ...
- Pilot SCS study planned for Céline Dion’s rare disorder Stiff-Person Syndromeon July 29, 2024 at 12:53 am
Researchers are looking at a pilot study to evaluate spinal cord stimulation (SCS) as a potential therapy for the treatment of painful spasms associated with Stiff-Person Syndrome (SPS). The rare, ...
- Parkinson’s Plus Syndrome: A new approach to treating a variant of Parkinson’s, a first in Indiaon July 27, 2024 at 7:27 pm
PPS, a variant of Parkinson's disease, presents a unique set of challenges including early-onset dementia, hallucinations and balance issues, making traditional medication ineffective. Mary's case was ...
- Spinal Cord Stimulation and Pain Relief in Painful Diabetic Peripheral Neuropathyon July 27, 2024 at 5:00 pm
Hence, it remains to be determined if SCS at both cervical and thoracal/lumbar spinal levels will be effective. These limitations notwithstanding and including the risks, our findings show that in ...
- Boston Scientific warns some Wavewriter Alpha SCS systems may stop and reset while chargingon July 26, 2024 at 8:51 am
Boston Scientific is warning that some WaveWriter Alpha spinal cord stimulation implantable pulse generator devices could suspend therapy.
- ONWARD® Medical Publishes Annual Sustainability Summaryon July 16, 2024 at 11:43 pm
EcoVadis, the world’s largest provider of business sustainability ratings, rated ONWARD Medical in the top 40% in the industry for its sustainability performance. The EcoVadis assessment evaluates 20+ ...
- Men with spinal cord injuries become fathers thanks to rare fertility treatment at Miami clinicon July 6, 2024 at 3:29 am
The two techniques include penile vibratory stimulation and electroejaculation, both FDA-approved and selected based on the nature of the spinal cord injury. The electroejaculation machine ...
via Bing News